Rogers Sugar (TSE:RSI) Price Target Lowered to C$5.25 at National Bank Financial

Share on StockTwits

Rogers Sugar (TSE:RSI) had its target price trimmed by National Bank Financial from C$5.50 to C$5.25 in a report released on Friday, BayStreet.CA reports. The firm currently has a sector perform rating on the stock.

A number of other research firms have also recently commented on RSI. BMO Capital Markets decreased their price objective on Rogers Sugar from C$6.00 to C$5.50 in a report on Friday, May 3rd. Desjardins decreased their price objective on Rogers Sugar from C$6.25 to C$6.00 in a report on Friday, May 3rd.

RSI opened at C$5.36 on Friday. Rogers Sugar has a one year low of C$5.23 and a one year high of C$6.17. The firm has a market capitalization of $562.84 million and a PE ratio of 13.71. The firm has a 50 day simple moving average of C$5.67. The company has a quick ratio of 0.80, a current ratio of 2.23 and a debt-to-equity ratio of 100.53.

Rogers Sugar Company Profile

Rogers Sugar Inc, through its subsidiary, Lantic Inc, engages in refining, packaging, and marketing sugar and maple products. It offers granulated, plantation raw, brown, organic, icing, maple, stevia, smart sweetener blend, and coconut sugar, as well as syrups, jam and jelly mixes, iced tea mixes, and hot chocolate mixes.

See Also: What is a Real Estate Investment Trust (REIT)?

Receive News & Ratings for Rogers Sugar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rogers Sugar and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Pinduoduo  Shares Up 16% After Better-Than-Expected Earnings
Pinduoduo Shares Up 16% After Better-Than-Expected Earnings
Stein Mart  Shares Up 19%
Stein Mart Shares Up 19%
Sienna Biopharmaceuticals  Stock Price Up 19.7%
Sienna Biopharmaceuticals Stock Price Up 19.7%
Harpoon Therapeutics  Stock Price Up 19.9%
Harpoon Therapeutics Stock Price Up 19.9%
XPEL  Stock Price Up 23.2%
XPEL Stock Price Up 23.2%
Arcadia Biosciences  Stock Price Up 25.4%
Arcadia Biosciences Stock Price Up 25.4%


© 2006-2019 Ticker Report